Junjie Ma

发表

Synthesis and Biological Evaluation of Benzothiazole Derivatives Bearing the ortho‐Hydroxy‐N‐acylhydrazone Moiety as Potent Antitumor Agents

X. Zhai, Guangyan Zhang, P. Gong, 2014, Archiv der Pharmazie.

Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.

P. Gong, Lihui Wang, Yanfang Zhao, 2014, European journal of medicinal chemistry.

Design and synthesis of novel 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridines as potential antitumor agents.

X. Zhai, H. Xie, Yucheng Gu, 2014, European journal of medicinal chemistry.

Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methylbiphenyl Moiety

Junjie Ma, Cuifang Wang, Kun Huang, 2019, Chemical Research in Chinese Universities.

Dual-Emissive Tris-Heteroleptic Ruthenium Complexes: Tuning the DNA-Triggered Ratiometric Emission Response by Ancillary Ligands.

Lianhui Wang, Yu‐Wu Zhong, Zhongliang Gong, 2021, Inorganic chemistry.

Synthesis and antitumor activities of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives

P. Gong, Yanfang Zhao, Junjie Ma, 2014, Chemical Research in Chinese Universities.

Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents.

X. Zhai, P. Gong, Limei Wang, 2015, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel benzothiazole derivatives bearing semicarbazone moiety as antitumor agents

P. Gong, Gang Hu, Junjie Ma, 2015, Chemical Research in Chinese Universities.

Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.

Jieqing Liu, Dandan Yuan, Junjie Ma, 2021, European journal of medicinal chemistry.

Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy.

Dandan Yuan, Junjie Ma, Roufen Chen, 2021, Future medicinal chemistry.

Advances in nonclassical phenyl bioisosteres for drug structural optimization.

Junjie Ma, Yali Gao, He Li, 2022, Future medicinal chemistry.

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells

N. Lin, Youyou Yan, Dan Liu, 2023, Frontiers in Pharmacology.

Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3.

Junjie Ma, Jiaan Liu, Yali Gao, 2019, MedChemComm.

Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020.

Junjie Ma, Yali Gao, Wenfa Chen, 2023, RSC medicinal chemistry.

Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells

P. Gong, Yanfang Zhao, Ye Tian, 2017 .

Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists.

Junjie Ma, Yali Gao, Hang Liu, 2024, ACS medicinal chemistry letters.